Literature DB >> 29431654

Enhanced Operant Extinction and Prefrontal Excitability in a Mouse Model of Angelman Syndrome.

Michael S Sidorov1,2,3, Matthew C Judson1,2,3, Hyojin Kim1,2,3, Marie Rougie1,2,3, Alejandra I Ferrer1,2,3, Viktoriya D Nikolova2,4, Natallia V Riddick2,4, Sheryl S Moy2,4, Benjamin D Philpot5,2,3.   

Abstract

Angelman syndrome (AS), a neurodevelopmental disorder associated with intellectual disability, is caused by loss of maternal allele expression of UBE3A in neurons. Mouse models of AS faithfully recapitulate disease phenotypes across multiple domains, including behavior. Yet in AS, there has been only limited study of behaviors encoded by the prefrontal cortex, a region broadly involved in executive function and cognition. Because cognitive impairment is a core feature of AS, it is critical to develop behavioral readouts of prefrontal circuit function in AS mouse models. One such readout is behavioral extinction, which has been well described mechanistically and relies upon prefrontal circuits in rodents. Here we report exaggerated operant extinction in male AS model mice, concomitant with enhanced excitability in medial prefrontal neurons from male and female AS model mice. Abnormal behavior was specific to operant extinction, as two other prefrontally dependent tasks (cued fear extinction and visuospatial discrimination) were largely normal in AS model mice. Inducible deletion of Ube3a during adulthood was not sufficient to drive abnormal extinction, supporting the hypothesis that there is an early critical period for development of cognitive phenotypes in AS. This work represents the first formal experimental analysis of prefrontal circuit function in AS, and identifies operant extinction as a useful experimental paradigm for modeling cognitive aspects of AS in mice.SIGNIFICANCE STATEMENT Prefrontal cortex encodes "high-level" cognitive processes. Thus, understanding prefrontal function is critical in neurodevelopmental disorders where cognitive impairment is highly penetrant. Angelman syndrome is a neurodevelopmental disorder associated with speech and motor impairments, an outwardly happy demeanor, and intellectual disability. We describe a behavioral phenotype in a mouse model of Angelman syndrome and related abnormalities in prefrontal cortex function. We hypothesize that robust and reliable prefrontally encoded behavior may be used to model cognitive impairments in Angelman syndrome.
Copyright © 2018 the authors 0270-6474/18/382671-12$15.00/0.

Entities:  

Keywords:  Angelman syndrome; UBE3A; excitability; extinction; prefrontal cortex

Mesh:

Substances:

Year:  2018        PMID: 29431654      PMCID: PMC5852653          DOI: 10.1523/JNEUROSCI.2828-17.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

Review 1.  Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions.

Authors:  David M Lonard; Carolyn L Smith
Journal:  Steroids       Date:  2002-01       Impact factor: 2.668

Review 2.  Channels underlying neuronal calcium-activated potassium currents.

Authors:  Pankaj Sah; E S Louise Faber
Journal:  Prog Neurobiol       Date:  2002-04       Impact factor: 11.685

3.  Medial dorsal hypothalamus mediates the inhibition of reward seeking after extinction.

Authors:  Nathan J Marchant; Teri M Furlong; Gavan P McNally
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

4.  The infralimbic cortex regulates the consolidation of extinction after cocaine self-administration.

Authors:  Ryan T LaLumiere; Kate E Niehoff; Peter W Kalivas
Journal:  Learn Mem       Date:  2010-03-23       Impact factor: 2.460

5.  Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model.

Authors:  Caroline F Bruinsma; Martijn Schonewille; Zhenyu Gao; Eleonora M A Aronica; Matthew C Judson; Benjamin D Philpot; Freek E Hoebeek; Geeske M van Woerden; Chris I De Zeeuw; Ype Elgersma
Journal:  J Clin Invest       Date:  2015-10-20       Impact factor: 14.808

6.  Activation of prefrontal cortical parvalbumin interneurons facilitates extinction of reward-seeking behavior.

Authors:  Dennis R Sparta; Nanna Hovelsø; Alex O Mason; Pranish A Kantak; Randall L Ung; Heather K Decot; Garret D Stuber
Journal:  J Neurosci       Date:  2014-03-05       Impact factor: 6.167

7.  Neurons in medial prefrontal cortex signal memory for fear extinction.

Authors:  Mohammed R Milad; Gregory J Quirk
Journal:  Nature       Date:  2002-11-07       Impact factor: 49.962

8.  UBE3A Regulates Synaptic Plasticity and Learning and Memory by Controlling SK2 Channel Endocytosis.

Authors:  Jiandong Sun; Guoqi Zhu; Yan Liu; Steve Standley; Angela Ji; Rashmi Tunuguntla; Yubin Wang; Chad Claus; Yun Luo; Michel Baudry; Xiaoning Bi
Journal:  Cell Rep       Date:  2015-07-09       Impact factor: 9.423

Review 9.  From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders.

Authors:  Michael B VanElzakker; M Kathryn Dahlgren; F Caroline Davis; Stacey Dubois; Lisa M Shin
Journal:  Neurobiol Learn Mem       Date:  2013-12-07       Impact factor: 2.877

Review 10.  The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome.

Authors:  Christian A Cea-Del Rio; Molly M Huntsman
Journal:  Front Cell Neurosci       Date:  2014-08-25       Impact factor: 5.505

View more
  9 in total

1.  Aberrant aggressive behavior in a mouse model of Angelman syndrome.

Authors:  Lilach Simchi; Hanoch Kaphzan
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

2.  Sex-Dependent Sensory Phenotypes and Related Transcriptomic Expression Profiles Are Differentially Affected by Angelman Syndrome.

Authors:  Lee Koyavski; Julia Panov; Lilach Simchi; Prudhvi Raj Rayi; Lital Sharvit; Yonatan Feuermann; Hanoch Kaphzan
Journal:  Mol Neurobiol       Date:  2019-01-31       Impact factor: 5.590

3.  Chronic α1-Na/K-ATPase inhibition reverses the elongation of the axon initial segment of the hippocampal CA1 pyramidal neurons in Angelman syndrome model mice.

Authors:  Prudhvi Raj Rayi; Alexei Y Bagrov; Hanoch Kaphzan
Journal:  Neuropsychopharmacology       Date:  2020-11-19       Impact factor: 7.853

Review 4.  Development of prefrontal cortex.

Authors:  Sharon M Kolk; Pasko Rakic
Journal:  Neuropsychopharmacology       Date:  2021-10-13       Impact factor: 7.853

5.  Dissociating motor impairment from five-choice serial reaction time task performance in a mouse model of Angelman syndrome.

Authors:  Paola N Negrón-Moreno; David T Diep; Caleigh D Guoynes; Michael S Sidorov
Journal:  Front Behav Neurosci       Date:  2022-09-23       Impact factor: 3.617

6.  Local axonal morphology guides the topography of interneuron myelination in mouse and human neocortex.

Authors:  Jeffrey Stedehouder; Demi Brizee; Johan A Slotman; Maria Pascual-Garcia; Megan L Leyrer; Bibi Lj Bouwen; Clemens Mf Dirven; Zhenyu Gao; David M Berson; Adriaan B Houtsmuller; Steven A Kushner
Journal:  Elife       Date:  2019-11-19       Impact factor: 8.140

7.  Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome.

Authors:  E L Berg; M C Pride; S P Petkova; R D Lee; N A Copping; Y Shen; A Adhikari; T A Fenton; L R Pedersen; L S Noakes; B J Nieman; J P Lerch; S Harris; H A Born; M M Peters; P Deng; D L Cameron; K D Fink; U Beitnere; H O'Geen; A E Anderson; S V Dindot; K R Nash; E J Weeber; M Wöhr; J Ellegood; D J Segal; J L Silverman
Journal:  Transl Psychiatry       Date:  2020-01-27       Impact factor: 6.222

8.  Visual Sequences Drive Experience-Dependent Plasticity in Mouse Anterior Cingulate Cortex.

Authors:  Michael S Sidorov; Hyojin Kim; Marie Rougie; Brittany Williams; Jennifer J Siegel; Jeffrey P Gavornik; Benjamin D Philpot
Journal:  Cell Rep       Date:  2020-09-15       Impact factor: 9.423

9.  Communication-related assessments in an Angelman syndrome mouse model.

Authors:  Peter A Perrino; Stormy J Chamberlain; Inge-Marie Eigsti; Roslyn Holly Fitch
Journal:  Brain Behav       Date:  2020-11-05       Impact factor: 2.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.